Stephen A. Sherwin SEC insider filings

Historical public-company ownership and transaction filings, with links to the original SEC records.

What the SEC filings show

Stephen A. Sherwin is named as a reporting owner in 12 source-backed SEC filings in this collection, associated with 6 public-company issuers. The most recent included filing was submitted Sep 3, 2026.

Filings may report stock transactions or holdings at a particular time. They do not establish the person's current share balance, portfolio value, total net worth, or whether a transaction was an open-market purchase or sale.

Source filings
12
Issuers represented
6
Filings with transactions
11
Filings with holdings
1

Recent SEC source documents

A selection of the latest 3 relevant source filings. Counts describe reported rows in the filing, not verified trades, economic proceeds, or personal profits. Older filings and amendments may contain different information.

FiledIssuerReported relationshipRowsOriginal SEC filing
Sep 3, 2026NEUROCRINE BIOSCIENCES INCDirector1 transaction / 0 holdingForm 4 · 0001079462-26-000008
Jun 26, 2015ADURO BIOTECH, INC.Director1 transaction / 0 holdingForm 4 · 0001209191-15-056936
Jun 26, 2015ADURO BIOTECH, INC.Director0 transaction / 3 holdingForm 3 · 0001209191-15-056935

How to interpret this evidence

SEC Forms 3, 4 and 5 disclose certain ownership and transaction observations. Reporting dates, beneficial ownership, derivative instruments, indirect positions and amendments can affect interpretation. Figures here are counts of filing records, not independent valuations. Exact total net worth is not publicly known from this filing record.

Browse this reporting owner's SEC filing history

Explore people and ownership research